By Dr. Edison de Mello
The recent push by the pharmaceutical industry to sell over-the-counter cholesterol-lowering drugs, or statins, (which include Lipitor, Zocor, Crestor and Pravachol), seem predicated on the recent report issued by the National Institute of Health and American Heart Association which suggest that more aggressive statin treatment leads to better results for people at moderate to high risk of heart disease, (defined as those with advancing age, high blood pressure or a family history of premature ...
Continue Reading →MAY